BBNX Beta Bionics, Inc. - Common Stock
$9,43
Precio · May 20, 2026
Fundamentales a fecha de Abr 21, 2026
Rango 52S
$9–$33
3% of range
Calificación del Analista
BUY
18 analysts
Precio Objetivo
$20
+115% upside
P/E (TTM)
-16.8
ROE
-24.9%
Margen de Beneficio Neto
-73.0%
BBNX Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
Precio
$9.43
Capitalización Bursátil
$1.35B
P/E (TTM)
-16.8
BPA (TTM)
$-1.81
Ingresos (TTM)
$100M
Rendimiento div.
—
ROE
-24.9%
Deuda/Capital
—
Rango 52S
$9 – $33
BBNX Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
Configure
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
Ingresos y Beneficio Neto
$100M
2023-12-31
→
2025-12-31
BPA
$-1.81
2023-12-31
→
2025-12-31
Flujo de caja libre
$-56M
2024-12-31
→
2025-12-31
Márgenes
-73.0%
2024-12-31
→
2025-12-31
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
Métrica
Tendencia a 5 años
BBNX
Mediana de Pares
P/E (TTM)
-16.8
376.8
P/S (TTM) (P/V (TTM))
13.5
6.5
P/B (P/C)
4.7
4.9
Price / FCF (Precio / FCF)
-24.0
—
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
Métrica
Tendencia a 5 años
BBNX
Mediana de Pares
Gross Margin (Margen Bruto)
55.4%
67.3%
Operating Margin (Margen Operativo)
-71.5%
—
Net Profit Margin (Margen de Beneficio Neto)
-73.0%
-30.7%
ROA
-30.6%
-14.1%
ROE
-24.9%
-25.6%
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
Métrica
Tendencia a 5 años
BBNX
Mediana de Pares
Current Ratio (Ratio corriente)
8.7
5.9
Quick Ratio (Ratio Rápido)
7.6
—
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
Métrica
Tendencia a 5 años
BBNX
Mediana de Pares
Revenue YoY (Ingresos interanuales)
53.9%
—
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
Métrica
Tendencia a 5 años
BBNX
Mediana de Pares
BBNX Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
COMPRA
18 analistas
- Compra fuerte 6 33,3%
- Compra 8 44,4%
- Mantener 4 22,2%
- Venta 0 0,0%
- Venta fuerte 0 0,0%
Precio objetivo a 12 meses
11 analistas · 2026-05-17
Mediana
$20.00
← Por Debajo de Todos los Objetivos
$9.43
Mín
$14.00
Máx
$32.00
Objetivo mediano
$20.00
+112,1%
Objetivo medio
$20.27
+115,0%
Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
Sorpresa Media
-0.02%
| Período | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|
| 31 de marzo de 2026 | $-0.49 | $-0.50 | 0.01% |
| 31 de diciembre de 2025 | $-0.29 | $-0.42 | 0.13% |
| 30 de septiembre de 2025 | $-0.33 | $-0.44 | 0.11% |
| 30 de junio de 2025 | $-0.39 | $-0.46 | 0.07% |
| 31 de marzo de 2025 | $-0.93 | $-0.49 | -0.44% |
Comparación con pares Métricas clave frente a competidores del sector
| Ticker | Capitalización Bursátil | P/E | Ingresos interanuales | Margen Neto | ROE | Margen Bruto |
|---|---|---|---|---|---|---|
| BBNX | $1.35B | -16.8 | 53.9% | -73.0% | -24.9% | 55.4% |
| TCMD | $651M | 35.4 | 12.5% | 5.8% | 9.2% | 75.9% |
| NPCE | $518M | -23.4 | 25.1% | -21.5% | -111.6% | 77.2% |
| OFIX | $604M | -6.5 | 2.9% | -11.2% | -20.3% | 68.8% |
| ANGO | $418M | -12.3 | -3.8% | -11.6% | -18.4% | 53.9% |
| VREX | $498M | -7.0 | 4.1% | -8.3% | -14.0% | 34.4% |
| DCTH | $350M | 144.3 | 129.1% | 3.2% | 2.5% | 86.2% |
| CLPT | $402M | -15.2 | 17.8% | -69.1% | -106.9% | 61.4% |
| CV | $501M | -10.4 | 15.3% | -186.8% | 40.3% | 52.9% |
| ISRG | $201.11B | 72.0 | 20.5% | 28.4% | 16.7% | 66.0% |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados 16
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue | $100M | $65M | $12M | |
| Cost of Revenue | $45M | $29M | $6M | |
| Gross Profit | $56M | $36M | $6M | |
| R&D Expense | $35M | $26M | $18M | |
| SG&A Expense | $31M | $18M | $12M | |
| Operating Expenses | $127M | $81M | $42M | |
| Operating Income | $-72M | $-45M | $-36M | |
| Interest Income | $11M | $4M | $2M | |
| Other Non-op | $-1.0K | $-2.0K | $-68.0K | |
| Income Tax | $0 | $0 | · | |
| Net Income | $-73M | $-55M | $-44M | |
| EPS (Basic) | $-1.81 | $-8.60 | $-8.31 | |
| EPS (Diluted) | $-1.81 | $-8.60 | $-8.31 | |
| Shares (Basic) | 40,529,051 | 6,365,064 | 5,303,684 | |
| Shares (Diluted) | 40,529,051 | 6,365,064 | 5,303,684 | |
| EBITDA | $-72M | $-45M | · |
Balance general 24
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Cash & Equivalents | $32M | $30M | $27M | |
| Short-term Investments | $188M | $73M | $70M | |
| Receivables | $17M | $12M | $4M | |
| Inventory | $22M | $13M | $1M | |
| Prepaid Expense | $10M | $4M | $1M | |
| Other Current Assets | · | $817.0K | $275.0K | |
| Current Assets | $268M | $133M | $104M | |
| PP&E (Net) | $9M | $5M | $2M | |
| PP&E (Gross) | $14M | $10M | $7M | |
| Accum. Depreciation | $6M | $5M | $4M | |
| Other Non-current Assets | $180.0K | $150.0K | $121.0K | |
| Total Assets | $329M | $150M | $110M | |
| Accounts Payable | $5M | $3M | $1M | |
| Current Liabilities | $31M | $21M | $11M | |
| Capital Leases | $5M | $6M | $3M | |
| Other Non-current Liabilities | $2M | · | · | |
| Total Liabilities | $41M | $74M | $51M | |
| Common Stock | $4.0K | $1.0K | · | |
| Paid-in Capital | $657M | $51M | $26M | |
| Retained Earnings | $-370M | $-297M | $-230M | |
| AOCI | $403.0K | $65.0K | $137.0K | |
| Stockholders' Equity | $288M | $-245M | $-203M | |
| Liabilities + Equity | $329M | $150M | $110M | |
| Shares Outstanding | 44,360,873 | 6,667,793 | · |
Flujo de Efectivo 9
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Stock-based Comp | $16M | $6M | $6M | |
| Operating Cash Flow | $-51M | $-48M | $-32M | |
| CapEx | $5M | $3M | $402.0K | |
| Investing Cash Flow | $-163M | $-3M | $-70M | |
| Stock Issued | $195M | · | · | |
| Net Stock Activity | $195M | · | · | |
| Financing Cash Flow | $215M | $56M | $101M | |
| Net Change in Cash | $1M | $4M | $-1M | |
| Free Cash Flow | $-56M | $-52M | · |
Rentabilidad 6
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Gross Margin | 55.4% | 55.1% | · | |
| Operating Margin | -71.5% | -69.5% | · | |
| Net Margin | -73.0% | -84.1% | · | |
| EBITDA Margin | -71.5% | -69.5% | · | |
| ROA | -30.6% | -42.2% | · | |
| ROE | -24.9% | 23.1% | · |
Liquidez y Solvencia 2
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Current Ratio | 8.7 | 6.3 | · | |
| Quick Ratio | 7.6 | 5.5 | · |
Eficiencia 3
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Asset Turnover | 0.4 | 0.5 | · | |
| Inventory Turnover | 2.6 | 4.0 | · | |
| Receivables Turnover | 6.9 | 7.9 | · |
Tasas de Crecimiento 1
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue YoY | 53.9% | 442.9% | · |
Valoración (TTM) 10
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue TTM | $100M | $65M | · | |
| Net Income TTM | $-73M | $-55M | · | |
| Market Cap | $1.35B | · | · | |
| P/E | -16.8 | · | · | |
| P/S | 13.5 | · | · | |
| P/B | 4.7 | · | · | |
| P / Tangible Book | 4.7 | · | · | |
| P / Cash Flow | -26.5 | · | · | |
| P / FCF | -24.0 | · | · | |
| Earnings Yield | -5.9% | · | · |
Estado de resultados 15
| Métrica | Tendencia | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $28M | $32M | $27M | $23M | $18M | $20M | $17M | $15M | $13M | |
| Cost of Revenue | $11M | $13M | $12M | $11M | $9M | $9M | $8M | $7M | $6M | |
| Gross Profit | $16M | $19M | $15M | $13M | $9M | $12M | $9M | $8M | $7M | |
| R&D Expense | $10M | $10M | $8M | $9M | $8M | $9M | $5M | $6M | $5M | |
| SG&A Expense | $10M | $9M | $8M | $8M | $7M | $5M | $5M | $5M | $4M | |
| Operating Expenses | $41M | $35M | $32M | $32M | $28M | $25M | $20M | $20M | $17M | |
| Operating Income | $-24M | $-16M | $-17M | $-20M | $-19M | $-13M | $-11M | $-12M | $-9M | |
| Interest Income | $2M | $3M | $3M | $3M | $2M | $951.0K | $826.0K | $993.0K | $1M | |
| Other Non-op | $2M | $10M | $1.0K | $-2.0K | $-10M | $0 | $-4.0K | $-2.0K | $4.0K | |
| Net Income | $-22M | $-13M | $-14M | $-17M | $-29M | $-18M | $-10M | $-14M | $-12M | |
| EPS (Basic) | $-0.49 | $-0.16 | $-0.33 | $-0.39 | $-0.93 | $-2.70 | $-1.46 | $-2.37 | $-2.07 | |
| EPS (Diluted) | $-0.49 | $-0.16 | $-0.33 | $-0.39 | $-0.93 | $-2.70 | $-1.46 | $-2.37 | $-2.07 | |
| Shares (Basic) | 44,436,274 | -77,210,376 | 43,634,006 | 43,390,652 | 30,714,769 | -12,423,124 | 6,660,493 | 6,105,813 | 6,021,882 | |
| Shares (Diluted) | 44,436,274 | -77,210,376 | 43,634,006 | 43,390,652 | 30,714,769 | -12,423,124 | 6,660,493 | 6,105,813 | 6,021,882 | |
| EBITDA | $-24M | · | $-17M | $-20M | $-19M | · | · | · | · |
Balance general 24
| Métrica | Tendencia | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $30M | $32M | $38M | $35M | $42M | $30M | · | · | · | |
| Short-term Investments | $169M | $188M | $190M | $215M | $189M | $73M | · | · | · | |
| Receivables | $16M | $17M | $12M | $11M | $9M | $12M | · | · | · | |
| Inventory | $24M | $22M | $20M | $17M | $16M | $13M | · | · | · | |
| Prepaid Expense | $9M | $10M | $9M | $8M | $6M | $4M | · | · | · | |
| Other Current Assets | · | · | $265.0K | $260.0K | $260.0K | · | · | · | · | |
| Current Assets | $248M | $268M | $270M | $286M | $262M | $133M | · | · | · | |
| PP&E (Net) | $10M | $9M | $7M | $6M | $6M | $5M | · | · | · | |
| PP&E (Gross) | $16M | $14M | $14M | $12M | $11M | $10M | · | · | · | |
| Accum. Depreciation | $6M | $6M | $6M | $6M | $6M | $5M | · | · | · | |
| Other Non-current Assets | $181.0K | $180.0K | $183.0K | $144.0K | $146.0K | $150.0K | · | · | · | |
| Total Assets | $304M | $329M | $330M | $330M | $338M | $150M | · | · | · | |
| Accounts Payable | $2M | $5M | $4M | $3M | $3M | $3M | · | · | · | |
| Current Liabilities | $23M | $31M | $25M | $19M | $16M | $21M | · | · | · | |
| Capital Leases | $5M | $5M | $6M | $5M | $5M | $6M | · | · | · | |
| Other Non-current Liabilities | $2M | $2M | $1M | $1M | · | · | · | · | · | |
| Total Liabilities | $33M | $41M | $35M | $28M | $24M | $74M | · | · | · | |
| Common Stock | $5.0K | $4.0K | $4.0K | $4.0K | $4.0K | $1.0K | · | · | · | |
| Paid-in Capital | $663M | $657M | $651M | $644M | $639M | $51M | · | · | · | |
| Retained Earnings | $-392M | $-370M | $-356M | $-342M | $-325M | $-297M | · | · | · | |
| AOCI | $-96.0K | $403.0K | $354.0K | $149.0K | $240.0K | $65.0K | · | · | · | |
| Stockholders' Equity | $271M | $288M | $295M | $302M | $314M | $-245M | · | · | · | |
| Liabilities + Equity | $304M | $329M | $330M | $330M | $338M | $150M | · | · | · | |
| Shares Outstanding | 44,561,695 | 44,360,873 | 43,991,598 | 43,465,136 | 43,353,890 | 6,667,793 | · | · | · |
Flujo de Efectivo 9
| Métrica | Tendencia | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $5M | $4M | $4M | $5M | $3M | $2M | $2M | $1M | $1M | |
| Operating Cash Flow | $-24M | $-9M | $-9M | $-14M | $-20M | $-14M | $-10M | $-12M | $-12M | |
| CapEx | $1M | $2M | $1M | $2M | $333.0K | $561.0K | $2M | $507.0K | $406.0K | |
| Investing Cash Flow | $22M | $658.0K | $9M | $6M | $-179M | $-30M | $15M | $3M | $8M | |
| Stock Issued | · | $-904.0K | $0 | $0 | $195M | · | · | · | · | |
| Net Stock Activity | · | · | · | · | $195M | · | · | · | · | |
| Financing Cash Flow | $623.0K | $1M | $3M | $42.0K | $211M | $57M | $-1M | $-107.0K | $6.0K | |
| Net Change in Cash | $-1M | $-7M | $3M | $-7M | $12M | $13M | $4M | $-9M | $-4M | |
| Free Cash Flow | $-25M | · | · | · | $-20M | · | · | · | · |
Rentabilidad 6
| Métrica | Tendencia | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 59.5% | · | 55.5% | 53.8% | 50.9% | · | · | · | · | |
| Operating Margin | -87.9% | · | -62.5% | -85.5% | -105.7% | · | · | · | · | |
| Net Margin | -79.3% | · | -52.1% | -72.6% | -162.5% | · | · | · | · | |
| EBITDA Margin | -87.9% | · | -62.5% | -85.5% | -105.7% | · | · | · | · | |
| ROA | -6.8% | · | -8.6% | -10.2% | -17.0% | · | · | · | · | |
| ROE | -7.5% | · | -9.6% | -11.2% | -18.3% | · | · | · | · |
Liquidez y Solvencia 2
| Métrica | Tendencia | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 10.7 | · | 10.6 | 14.7 | 15.9 | · | · | · | · | |
| Quick Ratio | 9.3 | · | 9.5 | 13.4 | 14.6 | · | · | · | · |
Eficiencia 3
| Métrica | Tendencia | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | · | 0.2 | 0.1 | 0.1 | · | · | · | · | |
| Inventory Turnover | 0.6 | · | 1.2 | 1.2 | 1.1 | · | · | · | · | |
| Receivables Turnover | 2.2 | · | 4.7 | 4.1 | 3.9 | · | · | · | · |
Valoración (TTM) 10
| Métrica | Tendencia | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $96M | · | $85M | $73M | $62M | · | · | · | · | |
| Net Income TTM | $-82M | · | $-69M | $-70M | $-65M | · | · | · | · | |
| Market Cap | $447M | · | $874M | $633M | $531M | · | · | · | · | |
| P/E | -4.7 | · | -6.4 | -2.8 | -1.8 | · | · | · | · | |
| P/S | 4.7 | · | 10.3 | 8.7 | 8.5 | · | · | · | · | |
| P/B | 1.6 | · | 3.0 | 2.1 | 1.7 | · | · | · | · | |
| P / Tangible Book | 1.6 | · | 3.0 | 2.1 | 1.7 | · | · | · | · | |
| P / Cash Flow | -18.7 | · | · | · | -26.6 | · | · | · | · | |
| P / FCF | -17.7 | · | · | · | -26.1 | · | · | · | · | |
| Earnings Yield | -21.4% | · | -15.7% | -35.4% | -55.8% | · | · | · | · |
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
Estado de resultados
| 2025-12-31 | 2024-12-31 | 2023-12-31 | |
|---|---|---|---|
| Ingresos | $100M | $65M | $12M |
| Margen Bruto % | 55.4% | 55.1% | — |
| Margen Operativo % | -71.5% | -69.5% | — |
| Beneficio neto | $-73M | $-55M | $-44M |
| EPS Diluido | $-1.81 | $-8.60 | $-8.31 |
Balance general
| 2025-12-31 | 2024-12-31 | 2023-12-31 | |
|---|---|---|---|
| Ratio corriente | 8.7 | 6.3 | — |
| Ratio Rápido | 7.6 | 5.5 | — |
Flujo de Efectivo
| 2025-12-31 | 2024-12-31 | 2023-12-31 | |
|---|---|---|---|
| Flujo de caja libre | $-56M | $-52M | — |
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
📊
Elige las métricas que te importan — haz clic en el ➕ junto a cualquier fila en Fundamentales Completos arriba.
Tu selección se guarda y te sigue en todos los tickers.